Story
SAP Surge Lifts German DAX by 1.33% Despite Rise in Volatility
Summary
German stocks closed higher on Friday, with the DAX index gaining 1.33%, propelled by a more than 9% rally in software firm SAP. The advance occurred even as the market's volatility gauge spiked to a one-month high.
German stocks finished the week on a positive note, with the blue-chip DAX index climbing significantly on Friday, largely driven by a powerful rally in shares of software giant SAP SE. The broad-based gains came despite a notable spike in a key market volatility indicator, suggesting underlying investor caution.
Market Snapshot
At the close in Frankfurt, Germany's benchmark DAX index was up 1.33%. Other major indices also posted gains:
- The mid-cap MDAX index rose 0.70%.
- The technology-focused TecDAX index advanced 1.84%.
Market breadth was positive, as rising stocks on the Frankfurt Stock Exchange outnumbered decliners by a margin of 407 to 247, with 30 issues ending the session unchanged.
Sector and Stock Movers
AdThe technology sector, specifically software, provided the primary impetus for Friday's rally. SAP SE (ETR:SAPG) was the session's standout performer, with its shares surging 9.26% to close at €140.20. The software company's strong performance made it the top gainer on both the DAX and TecDAX.
Other notable gainers on the DAX included Siemens Healthineers AG (ETR:SHLG), which added 3.03%, and Fresenius SE (ETR:FREG), which climbed 2.22%. However, the gains were not universal, with several major industrial and consumer names lagging. Volkswagen AG (ETR:VOWG_p) shares fell 2.03%, chipmaker Infineon Technologies AG (ETR:IFXGn) declined 1.65%, and Adidas AG (ETR:ADSGn) finished down 1.64%.
Volatility Jumps to 1-Month High
In a development that may temper investor optimism, the DAX volatility index (VIX), a measure of expected market turbulence derived from options prices, jumped 18.59% to 20.75. This marks a new one-month high for the index. A significant rise in volatility during a market rally can indicate underlying investor anxiety or hedging activity against potential future downturns.
In the broader commodities market, crude oil prices fell sharply, with the September Brent contract dropping over 4.5%. Meanwhile, gold futures for August delivery saw a modest increase of about 0.7%.
Read next
More on Stocks
CRISPR Therapeutics Faces Valuation Divide as Pipeline Hopes Clash With Cash Burn
The biotech pioneer is navigating a critical phase where its strong pipeline and first-approved drug, CASGEVY, are weighed against significant cash burn and a valuation that quantitative models flag as overextended.
Oura IPO Oversubscribed Fourfold with $2.2 Billion Target, Bloomberg Reports
The health and fitness ring maker has reportedly received orders for four times the number of shares available in its initial public offering, which aims to raise up to $2.2 billion.
Erste Group Bids for Majority Stake in Erste Bank Polska With Tender Offer
The Austrian lender plans to launch a cash tender offer for up to 26% of its Polish subsidiary at a discount to the market price, aiming to secure a controlling interest.
Mirum Pharmaceuticals Wins FDA Approval for Rare Bone Disorder Drug Atebrioz
The U.S. Food and Drug Administration has approved Mirum Pharmaceuticals' drug, Atebrioz (zilurgisertib), for treating fibrodysplasia ossificans progressiva (FOP), a rare genetic condition causing abnormal bone growth.